FDA rolls out new import guidelines, manufacturer flexibilities to boost infant formula supply

The Food and Drug Administration (FDA) on Monday announced a series of measures aimed at increasing the domestic U.S. supply of infant formula to counteract the current shortage, including temporary import guidelines and flexibilities for companies that don’t normally sell formula. The FDA said it will temporarily “not object” to the importation of certain infant formula products or the distribution of formula products that are manufactured in the U.S.
Read more...

;